Sentieo is a financial intelligence platform designed for investors, used by leading funds and asset managers worldwide to turn information into insights at market speed and transform their workflows into a competitive edge.

Alap Shah

Naman Shah

Sentieo

OnePlan offers an AI-enabled Strategic Portfolio, Financial, Resource, and Work Management Platform that connects with various tools for a complete view into all work across an enterprise. They provide solutions for strategic portfolio management, adaptive project portfolio management, and professional service automation, among others.

OnePlan

Atolio provides enterprise-level search solutions that allow organizations to retrieve and manage internal knowledge and data securely.

Atolio

CNS is a technology company that provides digital solutions to support enterprise and human development. The company offers services in data analytics, AI, software development, digital banking, and managed services.

AlphaSense

Sentieo, an AlphaSense company, provides the first financial intelligence platform specifically designed for the research needs of investors. Sentieo’s AI-powered financial search engine aggregates internal and external content into a single shared workspace for a more efficient research process. Over 1,100 global customers use Sentieo to surface, visualize, and share the insights that give them an edge.

The content of posts reference an opinion and / or is presented for product demonstration purposes. It is provided for information purposes only. It does not constitute, nor is it intended to be investment advice. Seek a duly licensed professional for investment advice.

Centana Growth Partners

Singh Capital Partners

Studio Management

Ten Coves Capital

Long Focus Capital

Clocktower Technology Ventures

Aniq Rahman

David Flaschen

Howard Lindzon

Scott Belsky

Sentieo, an AlphaSense company

"Everyone was frothing at the mouth over generative AI. But with good reason, I was just looking at the IDC numbers. And IDC is currently estimating that the global AI software revenue opportunity is $944 billion by 2027. I mean, that's a staggering number." - Michelle Brophy, Director of Technology, Media, and Telecommunications Research

In this 'Friday Coffee Talk,' Michelle shares her knowledge and domain expertise on trends in the TMT space. She dives deep, helping to provide valuable perspectives from industry insiders, including former employees, customers, suppliers, and more.

Her roundup session included topics (and related companies) like: 

- Key issues and debates of uptake in Enterprise for #genAI in 2024
- Implications of #genAI for the 2024 semiconductor ecosystem
- The rising need for cybersecurity amid digital transformation
- Pricing and consumer habit trends in streaming and media

Watch now ⤵ 
https://lnkd.in/eKUAZ_gb

The AlphaSense workforce is truly global, and we love to see our employees recognized by their local communities! Senior Software Engineer Luc Duong Tuan was featured in a Helsingin Sanomat article about his experience moving his family to Finland from Vietnam for a job at AlphaSense.

In the piece, Luc discusses the journey that led him to AlphaSense, how his family is adjusting to life in Finland, and how he advocates for Asians, both in his home of Vietnam and beyond, who are looking to live abroad. He hopes to be an example for others who may be intimidated by making a similar career leap or relocating their family.

Looking to make a career move? AlphaSense is hiring in Finland and across the globe. We'd love for you to join our growing team.

AlphaSense Careers:
https://lnkd.in/eQwwMJE

Read Luc's story:
https://lnkd.in/eBGaDNvQ

Interested in connecting directly with experts from AlphaSense transcripts for deeper insights beyond the text?

Our 'Talk to This Expert' feature, available in the AlphaSense expert transcript library, makes it easy. This useful button is embedded within each expert transcript and serves as your direct line to industry-leading minds. With just one click, you can leverage our Expert Call Services to dive deeper, engage in custom one-on-one calls, and gain insights you can’t find anywhere else!

Here's what you can gain:

1. Last-Mile Insights – Request clarification on specific topic points to ensure a comprehensive understanding of the expert’s perspective to fill gaps in your investment process.

2. Personalized Answers – Address your burning questions and identify potential red flags with expert insights most relevant to your individual research needs.

3. Fresh Perspectives – Hear the expert’s most recent insights unavailable anywhere else to gain a competitive edge.

Learn more:
https://lnkd.in/gJmExXS2

Join us at the upcoming Fierce BD&L Summit, in San Francisco! Cultivate connections with key dealmakers in life sciences, successfully identify and execute strategic partnerships, licensing, and M&A Deals this March 11-12, 2024.

We know that staying up to date on emerging competitors, evolving markets, disease areas, and investment opportunities is highly time-consuming and fragmented. AlphaSense ensures you find the information you need faster and before it’s on anyone else’s radar.

Stop by our booth to see the platform in action, or book a meeting with one of our team members here:
https://lnkd.in/emYCMQvv

View the agenda and save your seat now: 
https://lnkd.in/exeAQZJy

#FierceBDLSummit

We are thrilled to be attending BattleFin Alt Data Discovery Day Singapore!

Join AlphaSense at the iconic Marina Bay Sands as we present and tackle trends in the Asian Markets on March 20th and 21st.

Interested in joining us? Learn more: https://lnkd.in/g73FeRK3

#AltData #BattleFin #DiscoverDaySingapore

Watch reporters Lydia Ramsey Pflanzer, Lizzy Lawrence and Andrew Dunn  as they offer an insider's view and share key insights from the J.P. Morgan’s 42nd Annual Healthcare Conference!

The panel discussed:

- GLP-1 class of drugs for treating type-2 diabetes and obesity - what drugs have been dominating headlines not just in healthcare but also the mainstream media?

- Understanding what AI initiatives seem to have real substance vs. just a lot of hype.

- Buzz-worthy topics at the conference like cardiovascular/structural heart devices, IPO paperwork being filed, Amazon's work with Omada, and more!

Watch now ⤵ 
https://lnkd.in/ek9JF7fs

With recent approvals of costly gene therapies, debate grows on paying for innovation. With numerous early treatments in the pipeline, price and scaling may soon be obstacles. Longer term, FTC scrutiny of deals poses risks for biotech financing.

Join Rajesh Kumar, Head of European Life Sciences & Healthcare Equity Research, HSBC and Ryan Nagy, Account Manager - BioSciences, AlphaSense as they dive into the following topics and more:

✅ What companies are doing to get ahead
✅ How funding can be sourced
✅ An outlook on the path ahead

📅 Thursday, February 29th
⌚ 10 AM ET | 7 AM PT | 3PM GMT

Save your spot:
https://lnkd.in/eHUKngZn

Looking to join a high-growth company backed by the world’s leading investors? 

Business Insider listed AlphaSense as a company you should "bet your career on in 2024," at a time when layoffs and uncertainty in tech are rampant. We may be biased, but we agree! 

AlphaSense is hiring across the globe, and we'd love for you to join our growing team! 👉 https://lnkd.in/eQwwMJE

https://lnkd.in/gT9W4e2E

Expert Insights: Key Trends for Energy and Industrials in 2024

Amid interest rate hikes and slow renewable energy adoption, the energy and industrials (E&I) sector has grappled with significant challenges in recent years. With economic volatility persisting into 2024, industry leaders are focusing on essential trends and developments for the upcoming quarters.

We explore key trends within the E&I sector for 2024 by using valuable expert insights on bifurcated performance in construction, disappointing renewables adoption, and agricultural equipment.

https://lnkd.in/g9FUNTPX

What an incredible Sales Kickoff last week, gathering our Revenue team together in NOLA for three days of inspiring talks, customer panels, and training programs.

It's tough to pick a favorite SKO moment among so many, but as a founder, it's hard to beat our team stopping traffic as we walked across downtown New Orleans, led by a marching band... I had to pinch myself more than once!

Big thank you to our incredible customer and board panelists, and everyone in the Revenue Org that put together such an unforgettable experience for everyone!

For anyone interested in being a part of our amazing team, we are hiring across the organization - join us! https://lnkd.in/dUDDQHn8

Metric
Company Name	Sentieo	OnePlan	Atolio	CNS
Symbol
MSH ID	COM:SENTIEO	AI:ONEPLAN	COM:ATOLIO	COM:CNS-ME
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Financial Services & Finance	Technology	Technology	Technology
Industry	Financial Technology	Software Development	Information Technology	Information Technology
Country	US	US	US	AE
Stage
Employee Count	122
Website	sentieo.com	oneplan.ai	atolio.com	cns-me.com
LinkedIn	sentieo
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	47.77K	2.11K
Web Traffic Growth	16.90	1.96
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SENTIEO

Sentieo

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue